Skip to main content
Erschienen in: Clinical Research in Cardiology 6/2012

01.06.2012 | Original Paper

Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting

verfasst von: Jan-Malte Sinning, Viktoria Stoffel, Eberhard Grube, Georg Nickenig, Nikos Werner

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Risk stratification is essential for the clinical decision-making process in patients undergoing revascularization of the unprotected left main coronary artery (ULMCA), since the optimal revascularization strategy still remains subject of ongoing debate.

Objectives

To assess the prognostic value of angiographic versus clinical characteristics for the prediction of major adverse cardiac events (MACE) and to develop a combined risk model.

Methods

In 115 patients, who were followed up for MACE after ULMCA stenting, SYNTAX score and EuroSCORE have been calculated for a combined risk model.

Results

Whereas the SYNTAX score was not able to predict MACE at 1 year (32.8 ± 11.7 vs. 29.1 ± 12.2, P = 0.13), the logistic EuroSCORE was significantly increased in these patients suffering a MACE at 1 year [11.9 (4.4/22.6) vs. 4.8 (2.3/14.6)%, P = 0.007]. With ROC curve validated cut-off values, the combination of EuroSCORE (>7.5%) and SYNTAX score (>25) provided incremental predictive value for risk stratification of ULMCA patients (AUC 0.71, 95% CI 0.62–0.79, P < 0.001). This combined risk model was associated with the rate of cardiac mortality (P = 0.04), non-fatal myocardial infarction (P = 0.005), and target lesion revascularization (P = 0.04) and was superior to the SYNTAX score alone (P = 0.03). High risk patients had a 7.1-fold higher risk for MACE (HR 7.1. 95% CI 2.1–24.1, P = 0.002) after 1 year.

Conclusions

For adequate risk assessment in ULMCA patients, consideration of both comorbidities and coronary anatomic complexity, is essential. A combination of angiographic and clinical risk scores improves the prognostic value for the prediction of 1-year MACE risk and is superior to stand-alone scores.
Literatur
1.
Zurück zum Zitat Park SJ, Kim YH, Park DW et al (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364:1718–1727PubMedCrossRef Park SJ, Kim YH, Park DW et al (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364:1718–1727PubMedCrossRef
2.
Zurück zum Zitat Kappetein AP, Feldman TE, Mack MJ et al (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 32:2125–2134PubMedCrossRef Kappetein AP, Feldman TE, Mack MJ et al (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 32:2125–2134PubMedCrossRef
3.
Zurück zum Zitat Park DW, Seung KB, Kim YH et al (2010) Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 56:117–124PubMedCrossRef Park DW, Seung KB, Kim YH et al (2010) Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 56:117–124PubMedCrossRef
4.
Zurück zum Zitat Rodes-Cabau J, Deblois J, Bertrand OF et al (2008) Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 118:2374–2381PubMedCrossRef Rodes-Cabau J, Deblois J, Bertrand OF et al (2008) Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 118:2374–2381PubMedCrossRef
5.
Zurück zum Zitat Seung KB, Park DW, Kim YH et al (2008) Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358:1781–1792PubMedCrossRef Seung KB, Park DW, Kim YH et al (2008) Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358:1781–1792PubMedCrossRef
6.
Zurück zum Zitat Toyofuku M, Kimura T, Morimoto T et al (2009) Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Insights from the j-Cypher Registry. Circulation 120:1866–1874PubMedCrossRef Toyofuku M, Kimura T, Morimoto T et al (2009) Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Insights from the j-Cypher Registry. Circulation 120:1866–1874PubMedCrossRef
7.
Zurück zum Zitat Montalescot G, Brieger D, Eagle KA et al (2009) Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J 30:2308–2317PubMedCrossRef Montalescot G, Brieger D, Eagle KA et al (2009) Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J 30:2308–2317PubMedCrossRef
8.
Zurück zum Zitat Naik H, White AJ, Chakravarty T et al (2009) A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv. 2:739–747PubMedCrossRef Naik H, White AJ, Chakravarty T et al (2009) A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv. 2:739–747PubMedCrossRef
9.
Zurück zum Zitat Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C (2009) Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2:302–308PubMedCrossRef Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C (2009) Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2:302–308PubMedCrossRef
10.
Zurück zum Zitat Capodanno D, Miano M, Cincotta G et al (2010) EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 159:103–109PubMedCrossRef Capodanno D, Miano M, Cincotta G et al (2010) EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 159:103–109PubMedCrossRef
11.
Zurück zum Zitat Kim YH, Park DW, Kim WJ et al (2010) Validation of SYNTAX (synergy between PCI with TAXUS and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv 3:612–623PubMedCrossRef Kim YH, Park DW, Kim WJ et al (2010) Validation of SYNTAX (synergy between PCI with TAXUS and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv 3:612–623PubMedCrossRef
12.
Zurück zum Zitat Garg S, Sarno G, Girasis C et al (2011) A patient-level pooled analysis assessing the impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4:645–653PubMedCrossRef Garg S, Sarno G, Girasis C et al (2011) A patient-level pooled analysis assessing the impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4:645–653PubMedCrossRef
13.
Zurück zum Zitat Chakravarty T, Buch MH, Naik H et al (2011) Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 107:360–366PubMedCrossRef Chakravarty T, Buch MH, Naik H et al (2011) Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 107:360–366PubMedCrossRef
14.
Zurück zum Zitat Chen SL, Chen JP, Mintz G et al (2010) Comparison between the NERS (new risk stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. JACC Cardiovasc Interv 3:632–641PubMedCrossRef Chen SL, Chen JP, Mintz G et al (2010) Comparison between the NERS (new risk stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. JACC Cardiovasc Interv 3:632–641PubMedCrossRef
15.
Zurück zum Zitat Garg S, Sarno G, Garcia-Garcia HM et al (2010) A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX Score. Circ Cardiovasc Interv 3:317–326PubMedCrossRef Garg S, Sarno G, Garcia-Garcia HM et al (2010) A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX Score. Circ Cardiovasc Interv 3:317–326PubMedCrossRef
16.
Zurück zum Zitat Capodanno D, Caggegi A, Miano M et al (2011) Global risk classification and clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 4:287–297PubMedCrossRef Capodanno D, Caggegi A, Miano M et al (2011) Global risk classification and clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 4:287–297PubMedCrossRef
17.
Zurück zum Zitat de Mulder M, Gitt A, van Domburg R et al (2011) EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 32:1398–1408PubMedCrossRef de Mulder M, Gitt A, van Domburg R et al (2011) EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 32:1398–1408PubMedCrossRef
18.
Zurück zum Zitat Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555PubMedCrossRef Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555PubMedCrossRef
19.
Zurück zum Zitat Roques F, Nashef SA, Michel P et al (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822 (discussion 822–823)PubMedCrossRef Roques F, Nashef SA, Michel P et al (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822 (discussion 822–823)PubMedCrossRef
20.
Zurück zum Zitat Sianos G, Morel MA, Kappetein AP et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed Sianos G, Morel MA, Kappetein AP et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed
21.
Zurück zum Zitat Kushner FG, Hand M, Smith SCJ et al (2009) 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54:2205–2241PubMedCrossRef Kushner FG, Hand M, Smith SCJ et al (2009) 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54:2205–2241PubMedCrossRef
22.
Zurück zum Zitat Garg S, Stone GW, Kappetein AP, Sabik JF 3rd, Simonton C, Serruys PW (2010) Clinical and angiographic risk assessment in patients with left main stem lesions. JACC Cardiovasc Interv 3:891–901 Garg S, Stone GW, Kappetein AP, Sabik JF 3rd, Simonton C, Serruys PW (2010) Clinical and angiographic risk assessment in patients with left main stem lesions. JACC Cardiovasc Interv 3:891–901
23.
Zurück zum Zitat Serruys PW, Onuma Y, Garg S et al (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5:50–56PubMedCrossRef Serruys PW, Onuma Y, Garg S et al (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5:50–56PubMedCrossRef
24.
Zurück zum Zitat Capodanno D, Capranzano P, Di Salvo ME et al (2009) Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2:731–738PubMedCrossRef Capodanno D, Capranzano P, Di Salvo ME et al (2009) Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2:731–738PubMedCrossRef
25.
Zurück zum Zitat Shiomi H, Tamura T, Niki S et al (2011) Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 75:1130–1137PubMedCrossRef Shiomi H, Tamura T, Niki S et al (2011) Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 75:1130–1137PubMedCrossRef
26.
Zurück zum Zitat Kim YH, Ahn JM, Park DW et al (2006) EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 98:1567–1570PubMedCrossRef Kim YH, Ahn JM, Park DW et al (2006) EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 98:1567–1570PubMedCrossRef
27.
Zurück zum Zitat Rekik S, Brunet J, Bayet G et al (2011) EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty. Catheter Cardiovasc Interv 77:625–632PubMedCrossRef Rekik S, Brunet J, Bayet G et al (2011) EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty. Catheter Cardiovasc Interv 77:625–632PubMedCrossRef
28.
Zurück zum Zitat Michel P, Roques F, Nashef SA (2003) Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23:684–687 (discussion 687)PubMedCrossRef Michel P, Roques F, Nashef SA (2003) Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg 23:684–687 (discussion 687)PubMedCrossRef
29.
Zurück zum Zitat Romagnoli E, Burzotta F, Trani C et al (2009) EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 95:43–48PubMedCrossRef Romagnoli E, Burzotta F, Trani C et al (2009) EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 95:43–48PubMedCrossRef
30.
Zurück zum Zitat Onuma Y, Girasis C, Piazza N et al (2010) Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 3:584–594PubMedCrossRef Onuma Y, Girasis C, Piazza N et al (2010) Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 3:584–594PubMedCrossRef
Metadaten
Titel
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting
verfasst von
Jan-Malte Sinning
Viktoria Stoffel
Eberhard Grube
Georg Nickenig
Nikos Werner
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 6/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0417-5

Weitere Artikel der Ausgabe 6/2012

Clinical Research in Cardiology 6/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.